The Japanese government and ruling parties are revising health-insurance laws to add a 25% [1] patient surcharge on prescription drugs similar to over-the-counter medicines.
This measure aims to curb rising medical-care costs and lower the social-insurance premium burden on the working generation. By shifting costs for common medications to the patient, the government seeks to stabilize the national healthcare budget as costs continue to climb.
The legislation targets approximately 1,100 [2] items categorized as "OTC-like drugs," which are prescription medications that have the same active ingredients as those available without a prescription. The amendment was expected to be passed by the House of Councillors on May 29, 2024 [3].
According to government estimates, the shift in cost is expected to save the government roughly ¥90 billion [3] per year. The initiative is led by the Ministry of Health, Labour and Welfare, the Liberal Democratic Party, and the Japan Innovation Party [3].
Prime Minister Takashi Kōchi said it is necessary to strive to reduce the burden of insurance premiums by accumulating various reforms, not only the review of OTC-like drugs [3].
The policy reflects a broader effort to reorganize how the state subsidizes healthcare. By increasing the out-of-pocket cost for drugs that are readily available as over-the-counter options, the government intends to discourage the use of prescriptions for minor ailments that do not require physician-monitored medication.
“The Japanese government is adding a 25% patient surcharge on prescription drugs similar to over-the-counter medicines.”
This policy shift signals a tightening of Japan's universal healthcare coverage. By targeting 'OTC-like' drugs, the government is effectively redefining which medications are considered essential for state subsidy and which are viewed as consumer goods. This move is a strategic response to an aging population and a shrinking workforce, attempting to prevent the collapse of the insurance system by reducing the financial strain on younger workers.
